GRCE — Grace Therapeutics, Inc. · $35.0M cap

Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.

Use this GRCE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the GRCE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the GRCE SEC filings page. Lician reads the product cache first so this HTML stays unique to Grace Therapeutics, Inc. even when a live quote feed is slow.

Grace Therapeutics, Inc. latest statements (FY2026)

Latest cached year on this hub. Full GRCE income, balance, and cash tables.

  • Revenue$0
  • Net Income-$7.8M
  • Total Assets$66.7M
  • Total Debt$0
  • Free Cash Flow$0

GRCE recent filings